Charting a path forward for clinical research in artificial intelligence and gastroenterology. Issue 1 (19th April 2021)

• Record Type: Journal Article
• Authors: Glissen Brown, Jeremy R.; Waljee, Akbar K.; Mori, Yuichi; Sharma, Prateek; Berzin, Tyler M.
• Is Part Of: Digestive endoscopy. Volume 34:Issue 1(2022)
• Page Start: 4
• Page End: 12
• Publication Date: 2021-04-19
• Subjects: CONSORT‐AI -- deep learning -- guidelines -- machine learning -- SPIRIT‐AI; Digestive organs -- Diseases -- Periodicals; Digestive organs -- Diseases -- Diagnosis -- Periodicals; Endoscopy -- Periodicals; Digestive System Diseases -- diagnosis -- Periodicals; Digestive System Diseases -- therapy -- Periodicals; Endoscopy -- Periodicals; 616.3
• DOI: 10.1111/den.13974
• Languages: English
• ISSNs: 0915-5635

Abstract

Abstract : Gastroenterology has been an early leader in bridging the gap between artificial intelligence (AI) model development and clinical trial validation, and in recent years we have seen the publication of several randomized clinical trials examining the role of AI in gastroenterology. As AI applications for clinical medicine advance rapidly, there is a clear need for guidance surrounding AI‐specific study design, evaluation, comparison, analysis and reporting of results. Several initiatives are in the publication or pre‐publication phase including AI‐specific amendments to minimum reporting guidelines for clinical trials, society task force initiatives aimed at priority use cases and research priorities, and minimum reporting guidelines that guide the reporting of clinical prediction models. In this paper, we examine applications of AI in clinical trials and discuss elements of newly published AI‐specific extensions to the Consolidated Standards of Reporting Trials and Standard Protocol Items: Recommendations for Interventional Trials statements that guide clinical trial reporting and development. We then review AI applications at the pre‐trial level in both endoscopy and other subfields of gastroenterology and explore areas where further guidance is needed to supplement the current guidance available at the pre‐trial level.